Shaftesbury Capital (SHC) Competitors

GBX 128.90 +0.40 (+0.31%)

As of 05:59 AM Eastern

SHC vs. TALK, AMS, SSY, FME, and AGL

Should you buy Shaftesbury Capital stock or one of its competitors? MarketBeat compares Shaftesbury Capital with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shaftesbury Capital include TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Scisys Group (SSY), Future Metals (FME), and ANGLE (AGL). These companies are all part of the "healthcare" industry.

How does Shaftesbury Capital compare to TalkTalk Telecom Group?

TalkTalk Telecom Group (LON:TALK) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Shaftesbury Capital has lower revenue, but higher earnings than TalkTalk Telecom Group. TalkTalk Telecom Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TalkTalk Telecom Group	£1.52B	0.00	N/A	£12.80	N/A
Shaftesbury Capital	£238.90M	9.84	£39.54M	£18.50	6.97

TalkTalk Telecom Group pays an annual dividend of GBX 0.03 per share. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.9%. TalkTalk Telecom Group pays out 0.2% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Shaftesbury Capital has a consensus target price of GBX 184.50, suggesting a potential upside of 43.13%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, analysts plainly believe Shaftesbury Capital is more favorable than TalkTalk Telecom Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TalkTalk Telecom Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shaftesbury Capital	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

37.8% of Shaftesbury Capital shares are owned by institutional investors. 0.5% of Shaftesbury Capital shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Shaftesbury Capital has a net margin of 141.28% compared to TalkTalk Telecom Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat TalkTalk Telecom Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TalkTalk Telecom Group	N/A	N/A	N/A
Shaftesbury Capital	141.28%	8.78%	1.52%

In the previous week, Shaftesbury Capital had 1 more articles in the media than TalkTalk Telecom Group. MarketBeat recorded 1 mentions for Shaftesbury Capital and 0 mentions for TalkTalk Telecom Group. Shaftesbury Capital's average media sentiment score of 0.59 beat TalkTalk Telecom Group's score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the news media.

Company	Overall Sentiment
TalkTalk Telecom Group	Neutral
Shaftesbury Capital	Positive

Summary

Shaftesbury Capital beats TalkTalk Telecom Group on 12 of the 15 factors compared between the two stocks.

How does Shaftesbury Capital compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Shaftesbury Capital has a net margin of 141.28% compared to Advanced Medical Solutions Group's net margin of 4.35%. Shaftesbury Capital's return on equity of 8.78% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
Shaftesbury Capital	141.28%	8.78%	1.52%

22.6% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 37.8% of Shaftesbury Capital shares are owned by institutional investors. 4.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 0.5% of Shaftesbury Capital shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Shaftesbury Capital has higher revenue and earnings than Advanced Medical Solutions Group. Shaftesbury Capital is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.35	£11.22M	£4.52	54.87
Shaftesbury Capital	£238.90M	9.84	£39.54M	£18.50	6.97

Advanced Medical Solutions Group has a beta of 0.718, suggesting that its share price is 28% less volatile than the broader market. Comparatively, Shaftesbury Capital has a beta of 0.953, suggesting that its share price is 5% less volatile than the broader market.

Advanced Medical Solutions Group presently has a consensus target price of GBX 270.25, suggesting a potential upside of 8.97%. Shaftesbury Capital has a consensus target price of GBX 184.50, suggesting a potential upside of 43.13%. Given Shaftesbury Capital's higher probable upside, analysts plainly believe Shaftesbury Capital is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Shaftesbury Capital	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.1%. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.9%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Shaftesbury Capital is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Shaftesbury Capital had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for Shaftesbury Capital and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.16 beat Shaftesbury Capital's score of 0.59 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Medical Solutions Group	Positive
Shaftesbury Capital	Positive

Summary

Shaftesbury Capital beats Advanced Medical Solutions Group on 12 of the 16 factors compared between the two stocks.

How does Shaftesbury Capital compare to Scisys Group?

Scisys Group (LON:SSY) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

In the previous week, Shaftesbury Capital had 1 more articles in the media than Scisys Group. MarketBeat recorded 1 mentions for Shaftesbury Capital and 0 mentions for Scisys Group. Shaftesbury Capital's average media sentiment score of 0.59 beat Scisys Group's score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the news media.

Company	Overall Sentiment
Scisys Group	Neutral
Shaftesbury Capital	Positive

Scisys Group pays an annual dividend of GBX 0.02 per share. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.9%. Scisys Group pays out 1.4% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Shaftesbury Capital has a net margin of 141.28% compared to Scisys Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat Scisys Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scisys Group	N/A	N/A	N/A
Shaftesbury Capital	141.28%	8.78%	1.52%

Shaftesbury Capital has a consensus target price of GBX 184.50, suggesting a potential upside of 43.13%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, analysts clearly believe Shaftesbury Capital is more favorable than Scisys Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scisys Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shaftesbury Capital	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

37.8% of Shaftesbury Capital shares are owned by institutional investors. 0.5% of Shaftesbury Capital shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Shaftesbury Capital has higher revenue and earnings than Scisys Group. Scisys Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scisys Group	£59.06M	0.00	N/A	£1.40	N/A
Shaftesbury Capital	£238.90M	9.84	£39.54M	£18.50	6.97

Summary

Shaftesbury Capital beats Scisys Group on 13 of the 15 factors compared between the two stocks.

How does Shaftesbury Capital compare to Future Metals?

Shaftesbury Capital (LON:SHC) and Future Metals (LON:FME) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

In the previous week, Shaftesbury Capital had 1 more articles in the media than Future Metals. MarketBeat recorded 1 mentions for Shaftesbury Capital and 0 mentions for Future Metals. Shaftesbury Capital's average media sentiment score of 0.59 beat Future Metals' score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the media.

Company	Overall Sentiment
Shaftesbury Capital	Positive
Future Metals	Neutral

Shaftesbury Capital has a net margin of 141.28% compared to Future Metals' net margin of -1,051.73%. Shaftesbury Capital's return on equity of 8.78% beat Future Metals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shaftesbury Capital	141.28%	8.78%	1.52%
Future Metals	-1,051.73%	-11.89%	-11.36%

Shaftesbury Capital currently has a consensus target price of GBX 184.50, indicating a potential upside of 43.13%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, analysts plainly believe Shaftesbury Capital is more favorable than Future Metals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shaftesbury Capital	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Future Metals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Shaftesbury Capital has a beta of 0.953, suggesting that its stock price is 5% less volatile than the broader market. Comparatively, Future Metals has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

37.8% of Shaftesbury Capital shares are held by institutional investors. 0.5% of Shaftesbury Capital shares are held by insiders. Comparatively, 0.1% of Future Metals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Shaftesbury Capital has higher revenue and earnings than Future Metals. Future Metals is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shaftesbury Capital	£238.90M	9.84	£39.54M	£18.50	6.97
Future Metals	£155.84K	67.65	-£7.83M	-£0.40	N/A

Summary

Shaftesbury Capital beats Future Metals on 14 of the 16 factors compared between the two stocks.

How does Shaftesbury Capital compare to ANGLE?

Shaftesbury Capital (LON:SHC) and ANGLE (LON:AGL) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Shaftesbury Capital has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shaftesbury Capital	£238.90M	9.84	£39.54M	£18.50	6.97
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A

37.8% of Shaftesbury Capital shares are held by institutional investors. Comparatively, 17.5% of ANGLE shares are held by institutional investors. 0.5% of Shaftesbury Capital shares are held by insiders. Comparatively, 2.7% of ANGLE shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Shaftesbury Capital and Shaftesbury Capital both had 1 articles in the media. ANGLE's average media sentiment score of 0.67 beat Shaftesbury Capital's score of 0.59 indicating that ANGLE is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shaftesbury Capital	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ANGLE	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Shaftesbury Capital has a beta of 0.953, suggesting that its share price is 5% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market.

Shaftesbury Capital has a net margin of 141.28% compared to ANGLE's net margin of -732.40%. Shaftesbury Capital's return on equity of 8.78% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shaftesbury Capital	141.28%	8.78%	1.52%
ANGLE	-732.40%	-89.82%	-29.89%

Shaftesbury Capital currently has a consensus target price of GBX 184.50, indicating a potential upside of 43.13%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, equities analysts plainly believe Shaftesbury Capital is more favorable than ANGLE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shaftesbury Capital	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
ANGLE	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Shaftesbury Capital beats ANGLE on 13 of the 15 factors compared between the two stocks.

Get Shaftesbury Capital News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Shaftesbury Capital	REIT Industry	Real Estate Sector	LON Exchange
Market Cap	£2.35B	£3.15B	£1.90B	£2.78B
Dividend Yield	3.13%	5.74%	6.93%	6.09%
P/E Ratio	6.97	5.08	27.17	365.94
Price / Sales	9.84	290.43	842.92	88,399.10
Price / Cash	N/A	113.05	68.06	27.89
Price / Book	0.67	2.38	1.30	7.72
Net Income	£39.54M	£89.50M	-£124.57M	£5.89B
7 Day Performance	-3.23%	-0.50%	-0.72%	0.49%
1 Month Performance	-7.07%	0.91%	-0.30%	2.48%
1 Year Performance	-8.19%	17.75%	3.91%	87.19%

Shaftesbury Capital Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Shaftesbury Capital	3.4547 of 5 stars	GBX 128.90 +0.3%	GBX 184.50 +43.1%	-7.9%	£2.35B	£238.90M	6.97	3,000
TALK TalkTalk Telecom Group	N/A	N/A	N/A	N/A	£1.11B	£1.52B	7.57	500	High Trading Volume
AMS Advanced Medical Solutions Group	1.7678 of 5 stars	GBX 248 +0.2%	GBX 270.25 +9.0%	+29.6%	£537.95M	£228.94M	54.87	10	Positive News
SSY Scisys Group	N/A	N/A	N/A	N/A	£75.14M	£59.06M	180.71	1,376
FME Future Metals	N/A	GBX 1.10 -2.2%	N/A	+120.0%	£10.54M	£155.84K	N/A	123,200	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SHC) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shaftesbury Capital (SHC) Competitors

SHC vs. TALK, AMS, SSY, FME, and AGL

How does Shaftesbury Capital compare to TalkTalk Telecom Group?

Summary

How does Shaftesbury Capital compare to Advanced Medical Solutions Group?

Summary

How does Shaftesbury Capital compare to Scisys Group?

Summary

How does Shaftesbury Capital compare to Future Metals?

Summary

How does Shaftesbury Capital compare to ANGLE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Shaftesbury Capital Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shaftesbury Capital (SHC) Competitors

SHC vs. TALK, AMS, SSY, FME, and AGL

How does Shaftesbury Capital compare to TalkTalk Telecom Group?

Which has stronger earnings & valuation, TALK or SHC?

Is TALK or SHC a better dividend stock?

Do analysts prefer TALK or SHC?

Do institutionals & insiders have more ownership in TALK or SHC?

Is TALK or SHC more profitable?

Does the media refer more to TALK or SHC?

Summary

How does Shaftesbury Capital compare to Advanced Medical Solutions Group?

Is AMS or SHC more profitable?

Do institutionals & insiders have more ownership in AMS or SHC?

Which has stronger earnings & valuation, AMS or SHC?

Which has more risk and volatility, AMS or SHC?

Do analysts prefer AMS or SHC?

Is AMS or SHC a better dividend stock?

Does the media refer more to AMS or SHC?

Summary

How does Shaftesbury Capital compare to Scisys Group?

Does the media prefer SSY or SHC?

Is SSY or SHC a better dividend stock?

Is SSY or SHC more profitable?

Do analysts recommend SSY or SHC?

Do institutionals and insiders believe in SSY or SHC?

Which has better valuation & earnings, SSY or SHC?

Summary

How does Shaftesbury Capital compare to Future Metals?

Does the media refer more to SHC or FME?

Is SHC or FME more profitable?

Do analysts prefer SHC or FME?

Which has more risk and volatility, SHC or FME?

Do institutionals & insiders hold more shares of SHC or FME?

Which has preferable earnings & valuation, SHC or FME?

Summary

How does Shaftesbury Capital compare to ANGLE?

Which has higher valuation and earnings, SHC or AGL?

Do insiders and institutionals hold more shares of SHC or AGL?

Does the media refer more to SHC or AGL?

Which has more risk & volatility, SHC or AGL?

Is SHC or AGL more profitable?

Do analysts prefer SHC or AGL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Shaftesbury Capital Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools